Alternative dosing of dual PI3K and MEK inhibition in cancer therapyElina Jokinen(Oulu University Hospital), Jussi Koivunen(Oulu University Hospital)BMC CancerDecember 1, 201210.1186/1471-2407-12-612Cited by 40SaveCiteExport RISWatch citationsRelated PapersProtein Kinase C α/β Inhibitor Go6976 Promotes Formation of Cell Junctions and Inhibits Invasion of Urinary Bladder Carcinoma Cells|Cancer Research|2004|103Prognostic and predictive role of tumour-associated macrophages in HER2 positive breast cancer|Scientific Reports|2019|96Role of human epidermal growth factor receptor 3 in treatment resistance of anaplastic lymphoma kinase translocated non-small cell lung cancer|Cancer Biology & Therapy|2023|2